“…The group of selected analytes comprised: five purine derivatives ( 1–5 ) with relevant activity against human breast cancer cell line MCF‐7 (Díaz‐Gavilán et al ., ; Conejo‐García et al ., ; Natalini et al ., ); two nonsteroidal agonists of the Farnesoid X Receptor ( 6 , 7 ) (Marinozzi et al ., ), a promising target for the treatment of a variety of metabolic disorders, including hyperlipidemia, cholelithiasis, cholestasis and diabetes mellitus; a conformationally restricted β‐amino acid ( 8 ) to be evaluated as angiotensin converting enzyme inhibitor (Sternativo et al ., ); and the E‐ and Z‐guggulsterones ( 9 , 10 ), especially known for their ability to reduce lipid and cholesterol levels (Gioiello et al ., ), for their utility in the treatment of various cardiovascular diseases, and to be endowed with anti‐neoplastic properties.…”